Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Feb 10, 2021 10:27am
274 Views
Post# 32524463

RE:RE:RE:RE:RE:RE:RE:Flad

RE:RE:RE:RE:RE:RE:RE:FladI hear you....but this stock and pretty well all others aren't going to or shouldn't at least, trade on fundamentals, at least not yet.  Although LABs seems like it's one of few that do.

No doubt all involved still have a$$ hurt from Q3....Q4 may not be better but I can't see it being worse...but that's what we thought Q3...hahaha.

I gotta believe that we're pretty much middling down at the base now and it's only up from here.  How quick and how far, that's the million dollar question.  Not happy nor impressed with where the SP ended up, but still very impressed with all of the deals and positive movement the world over to set them up for possible success; garbage financing nothwithstanding.

Tons of shyte can still pull the rug out, but they've done alot of things right...we can only hope that pays off in the medium term.  We'll see where this much hyped international update goes.....I would be stunned that they would reference something like that only to put it out there with it being a dud....could be they're holding off until Stada takes delivery, or the germans finally got off their a$$ and certify the Barrie plant....



Lemoyne wrote: OGI is wayyyy overvalued, most probably getting squeezed.

What I mean is valuation relative to numbers at hand and the trend over the past year.

Q4 revenues and local and intl progress are not inked in, and I doubt we will see a 200% increase in revenues corresponding to the 200% increase in units shipped. If we do, LABS will skyrocket, regardless of writedowns. But we got f*cked so hard in Q3, I have doubts about Q4 and am conservative for 2021.

And you see I'm not the only one thinking a buck is too much even with all the momentum. it barely touched 1.00.

I do feel a good intl update or rockstar CEO could justify a hike above 1$, but otherwise, it's very high risk trading above 1.




<< Previous
Bullboard Posts
Next >>